Of note, we noticed that information on the role of MCP-1 in RA-ILD+ was limited to a single study in Asian population that also showed the same differences between RA-ILD+ and RA-ILD− patients (Ling et al., 2010). This evidence concerns the gene CCL2 and interstitial lung disease.